S&P 500
754.19
-0.39%
DOW
522.93
+0.09%
NASDAQ
680.79
-1.07%
Russell
277.82
-0.22%
VIX
18.03
+3.92%
FTSE
47.96
+0.42%
Nikkei
91.79
+0.35%
BTC
68,937.93
-3.65%
ETH
1,950.63
-3.41%
Gold
355.42
+0.15%
Oil
145.48
-0.40%
Silver
44.12
-2.22%
S&P 500
754.19
-0.39%
DOW
522.93
+0.09%
NASDAQ
680.79
-1.07%
Russell
277.82
-0.22%
VIX
18.03
+3.92%
FTSE
47.96
+0.42%
Nikkei
91.79
+0.35%
BTC
68,937.93
-3.65%
ETH
1,950.63
-3.41%
Gold
355.42
+0.15%
Oil
145.48
-0.40%
Silver
44.12
-2.22%
Stock
Ti
News
Markets
Stocks
Screener
Calendar
Watchlist
Loading...
Home
/
Stocks
/
TNXP
/
News
TNXP
NASDAQ · Biotechnology
Tonix Pharmaceuticals Holdin
Penny Stocks
Biotech Stocks
Healthcare Stocks
$3.01
-0.23 (-7.10%)
☆ Watch
As of Nov 15, 10:38 PM ET ·
Overview
Earnings
Forecast
Financials
News
Peers
TNXP News
1 articles
Tonix Pharma Surges on Promising Lyme Antibody Data; Phase 2 Trial Eyed for 2027
Tonix Pharmaceuticals shares rose after new Phase 1 modeling data for its Lyme antibody TNX-4800 showed six-month protection with two doses. A Phase 2 trial is targeted for 2027.
Markets
May 15
↑